CME Group will explore improving capital market efficiency b

CME Group will explore improving capital market efficiency by piloting tokenization technology built on Google Cloud's Universal Ledger, with trials scheduled for 2026.#CLOUD 

Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.

Explore the latest crypto news

⚡️ Be a part of the latests discussions in crypto

💬 Interact with your favorite creators

👍 Enjoy content that interests you

Email / Phone number

Relevant Creator

coolguy_pintu

@coolguy_pintu

Explore More From Creator

Ethereum developer Virgil Griffith has been released from prison after serving 63 months for a US sanctions violation. The violation was linked to a 2019 speech he gave in North Korea regarding blockchain use. $ETH #MarketRebound

A Hyperliquid trader has executed a very large trade, a 20x long position on $ETH at $1,459. With a liquidation price of $1,391, they are currently showing a $344,458 unrealized profit.

Kyrgyz Republic partners with CZ to develop crypto and blockchain ecosystem. #blockchains

House Financial Services Committee passes 'STABLE Act' to regulate stablecoins. #TrumpTariffs #BinanceAlphaAlert

#altcoins chart is coming years ?? #WhaleMovements

Latest News

U.S. Consumer Confidence Plummets to Crisis Levels

Navarro Criticizes Media's Role in Trump's Trade Agenda

Movement Labs Initiates Thorough Review of Market Maker Anomalies

Tether Acquires Majority Stake in Adecoagro, Board Undergoes Major Changes

Security Concerns Rise for Crypto Industry Amid Increasing Threats

.css-1iqe90x{box-sizing:border-box;margin:0;min-width:0;color:#EAECEF;}CME Group will explore improving capital market efficiency by piloting tokenization technology built on Google Cloud's Universal Ledger, with trials scheduled for 2026.

Explore More From Creator

Latest News

Trending Articles

CME Group will explore improving capital market efficiency by piloting tokenization technology built on Google Cloud's Universal Ledger, with trials scheduled for 2026.